ATE546547T1 - Diagnose der chronischen abstossung - Google Patents

Diagnose der chronischen abstossung

Info

Publication number
ATE546547T1
ATE546547T1 AT03792410T AT03792410T ATE546547T1 AT E546547 T1 ATE546547 T1 AT E546547T1 AT 03792410 T AT03792410 T AT 03792410T AT 03792410 T AT03792410 T AT 03792410T AT E546547 T1 ATE546547 T1 AT E546547T1
Authority
AT
Austria
Prior art keywords
transplanted subject
chronic rejection
diagnosis
transplanted
subject
Prior art date
Application number
AT03792410T
Other languages
English (en)
Inventor
Andreas Krause
Detlef Niese
Friedrich Raulf
Andreas Scherer
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE546547T1 publication Critical patent/ATE546547T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT03792410T 2002-08-22 2003-08-21 Diagnose der chronischen abstossung ATE546547T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40522502P 2002-08-22 2002-08-22
PCT/EP2003/009292 WO2004018710A2 (en) 2002-08-22 2003-08-21 Diagnosis of chronic rejection

Publications (1)

Publication Number Publication Date
ATE546547T1 true ATE546547T1 (de) 2012-03-15

Family

ID=31946831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03792410T ATE546547T1 (de) 2002-08-22 2003-08-21 Diagnose der chronischen abstossung

Country Status (7)

Country Link
US (1) US20060099591A1 (de)
EP (1) EP1532278B1 (de)
JP (1) JP2005536212A (de)
AT (1) ATE546547T1 (de)
AU (1) AU2003258648A1 (de)
ES (1) ES2380929T3 (de)
WO (1) WO2004018710A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4316617B2 (ja) * 2003-12-03 2009-08-19 ノバルティス アクチエンゲゼルシャフト 移植片拒絶反応のバイオマーカー
JP2006014722A (ja) * 2004-06-02 2006-01-19 Keio Gijuku 遺伝子マーカー及びその利用
GB0605217D0 (en) 2006-03-15 2006-04-26 Novartis Ag Method and compositions for assessing acute rejection
GB0606776D0 (en) * 2006-04-03 2006-05-10 Novartis Pharma Ag Predictive biomarkers for chronic allograft nephropathy
GB0607943D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Biomarkers for chronic transplant dysfunction
CA2650507A1 (en) * 2006-04-27 2007-11-08 Universite De Montreal Assessment and reduction of risk of graft-versus-host disease
EP2049713A4 (de) * 2006-07-21 2010-06-16 Univ Alberta Gewebeabstossung
EP2031073A1 (de) * 2007-08-31 2009-03-04 TC LAND Expression Diagnose von Immuntransplantatstoleranz mittels TMTC3-Genexpressionsebenen
DK3234599T3 (da) * 2014-12-19 2020-05-04 Inst Nat Sante Rech Med Fremgangsmåder til forudsigelse af transplantatforandringer
WO2019139595A1 (en) * 2018-01-11 2019-07-18 Visa International Service Association Offline authorization of interactions and controlled tasks

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883082A (en) * 1990-08-14 1999-03-16 Isis Pharmaceuticals, Inc. Compositions and methods for preventing and treating allograft rejection
ZA927323B (en) 1991-09-24 1993-08-30 Keygene Nv Selective restriction fragment amplification: A general method for DNA fingerprinting
US6187534B1 (en) * 1997-09-24 2001-02-13 Cornell Research Foundation, Inc. Methods of evaluating transplant rejection

Also Published As

Publication number Publication date
EP1532278B1 (de) 2012-02-22
ES2380929T3 (es) 2012-05-21
AU2003258648A1 (en) 2004-03-11
EP1532278A2 (de) 2005-05-25
WO2004018710A2 (en) 2004-03-04
JP2005536212A (ja) 2005-12-02
US20060099591A1 (en) 2006-05-11
WO2004018710A3 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
WO2005054503A3 (en) Biomarkers for graft rejection
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
WO2006128192A3 (en) Use of free circulating dna for diagnosis, prognosis, and treatment of cancer
WO2005020784A3 (en) Surrogate cell gene expression signatures for evaluating the physical state of a subject
EP2177908A3 (de) Mit Diabetes assoziierte Marker und Verfahren zur Verwendung davon
ATE419390T1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
ATE546547T1 (de) Diagnose der chronischen abstossung
WO2008063479A3 (en) Pancreatic cancer biomarkers
WO2007053785A3 (en) Method for early detection of various cancers and gastrointestinal disease and monitoring of transplanted organs.
WO2005028675A3 (en) Methods for detecting, diagnosing and treating hepatocellular carcinomas (hcc)
NO20072853L (no) Diagnose og prognose av infeksjonssykdommers kliniske fenotype og andre fysiologiske tilstander ved anvendelse av genekspresjon av biomarkorer i vertens blod
WO2008134569A3 (en) Diagnosis and treatment of inflammatory bowel disease in the puerto rican population
WO2006089233A3 (en) Methods and systems for diagnosis, prognosis and selection of treatment of leukemia
DE60331941D1 (de) Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
WO2006027192A3 (en) Biomarkers for acute graft rejection
DE69940465D1 (de) Verfahren zum nachweis und hemmung der angiogenese
WO2004021008A3 (en) Methods for detecting breast and ovarian cancer
WO2005048818A3 (en) Methods of diagnosing renal disease
ATE354097T1 (de) Verfahren zur diagnose von leberfibrose.
WO2006133287A3 (en) Expression profiles of peripheral blood mononuclear cells for inflammatory bowel diseases
ATE415632T1 (de) Verfahren zur diagnose und behandlung von morbus crohn
JP6062103B2 (ja) 膵臓疾患判定のための方法
DE502006008028D1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
CA2575405A1 (en) Method for diagnosing liver fibrosis